One in 10 medical products circulating in low—and middle-income countries (LMICs) is substandard or fake, with the majority in Sub-Saharan Africa being antibacterial and antimalarial drugs. The ...

Substandard and falsified medicines are a growing global threat, driving antimicrobial resistance and significantly affecting public health, particularly in low-income countries.

Citing "objectionable conditions," the agency said there were problems with the way Raptim Research tested medicines in India ...

The WHO’s 2025 report highlights global disparities in the detection of substandard and falsified medical products, emphasizing the need for stronger legal frameworks, technical capacity, and ...

To curb the influx of substandard and falsified medicines into Nigeria, the National Agency for Food and Drug Administration ...

as part of its intensified efforts to prevent the importation of substandard and falsified (SF) medicines and other regulated products from India and China, it emerged on Sunday. The appointment ...

The public alert with No. 07/2025 was uploaded on the agency’s website on Thursday. The agency said the issue about falsified medicine was reported to the World Health Organisation (WHO) by the ...

NAFDAC has appointed Cotecna Inspection Services as a Clean Report of Inspection and Analysis (CRIA) agent in India in a ...

The scale of the problem was highlighted in March when authorities set ablaze $645 million worth of counterfeit medicines ...